Drug acceptance is a essentially very long course of action, but for cannabis there have been the extra hurdles of legal roadblocks, along with the problem in getting patent protections for organic compounds.Synthetic cannabinoids (SCs) are a class of compounds similar in pharmacological and physiological outcomes to tetrahydrocannabinol (THC), the